Public Board papers 31.03.22

2. To be an international leader in research and innovation which leads to direct patient benefits at all stages of the cancer journey Annual objective Measure Timescale Director

Progress

2.1 Work in collaboration with regional, national and international research partners to provide world class cancer research

Refresh and embed new R&I strategy in alignment with other Christie clinical strategies and NIHR Biomedical Research Centre, Experimental Cancer Medicine Centre, Clinical Research Facility and CRUK Major Centre strategic objectives

31.03.23

DCEO/DRI

Completion of the of the Paterson development

31.03.23

EDoF

3. To be an international leader in professional and public education for cancer care Annual objective Measure

Timescale

Director

Progress

3.1 Refresh and implement the Christie Education Strategic Plan

Strategic plan approved with a focus on transforming cancer care through excellence in education and scholarship regionally, nationally and internationally

31.3.23

DCEO/DE

3.2 Increase accessibility to cancer education Embed an expansive portfolio of inclusive cancer education programmes with a strong focus of personalised learning that supports all Christie staff and external colleagues

31.3.23

DCEO/DE

4. To integrate our clinical, research and educational activities as an internationally recognised and leading comprehensive cancer centre Annual objective Measure Timescale Director Progress 4.1 Develop and implement Christie Clinical Outcomes Strategy Outcomes strategy approved and implementation commenced to;

• improve clinical data documentation • streamline access to clinical data • optimise use of clinical data to drive service delivery / improvement and research • elevate ability to monitor key outcome metrics • increase data literacy Expand education offer to international partners and international clinical fellowship scheme

31.3.23

EMD

4.2 Enhance and expand Christie International partnerships

31.3.23

DCEO/DE

124